Chapter 24

CARE OF PATIENTS WITH NONINFECTIOUS LOWER RESPIRATORY PROBLEMS

ASTHMA

  • Definition: Chronic disorder affecting the airways characterized by
      - Clinical Manifestations:
        - Mucosal edema
        - Bronchoconstriction
        - Excessive mucous production
      - Obstruction Mechanisms:
        - Inflammation
        - Airway hyperresponsiveness

  • Affected Areas: Primarily impacts the airways, NOT the alveoli.

ASSESSMENT OF ASTHMA

  • Adapted from Global Initiative for Asthma (GINA) 2018.

  • Severity Classification:
      - Mild Intermittent: Symptoms occur less than twice a week.
      - Mild Persistent: Symptoms arise more than twice a week but not daily.
      - Moderate Persistent: Daily symptoms with exacerbations twice a week.
      - Severe Persistent: Continual symptoms with frequent exacerbations limiting physical activity and quality of life.

ASSESSMENT OF ASTHMA (2)

  • Patient History:
      - Onset and duration of symptoms
      - Precipitating factors (stress, exercise, irritant exposure)
      - Changes in medication regimen
      - Smoking history
      - Medications for relief
      - Other medications taken
      - Self-care methods for relief

  • Physical Symptoms:
      - Dyspnea
      - Chest tightness
      - Anxiety or stress
      - Coughing
      - Wheezing
      - Mucous production
      - Use of accessory muscles
      - Prolonged exhalation
      - Poor oxygen saturation
      - Barrel chest: Appearance indicator of chronic respiratory conditions.

ASTHMA: LABORATORY ANALYSIS

  • Arterial Blood Gases (ABGs):
      - Hypoxemia: Decreased PaO2PaO_2
      - Hypocarbia: Decreased PaCO2PaCO_2 (early in the attack)
      - Hypercarbia: Increased PaCO2PaCO_2 (later in the attack)

  • Sputum Cultures:
      - Bacteria can indicate infection
      - Allergic asthma may show:
        - Elevated serum eosinophil counts
        - Elevated immunoglobulin (IgE) levels

ASTHMA: DIAGNOSTICS

  • Pulmonary Function Tests (PFTs): Most accurate for diagnosing asthma and its severity.
      - Forced Vital Capacity (FVC): Volume of air exhaled from full inhalation to full exhalation.
      - Forced Expiratory Volume in the First Second (FEV1): Volume of air blown out hard and fast during the first second of exhalation after full inhalation.
      - Peak Expiratory Flow: Fastest airflow rate during exhalation.
      - A decrease in FEV1 by 15% to 20% below expected values is common in asthma.
      - An increase of 12% following bronchodilator administration is diagnostic for asthma.
      - Chest X-ray: Used to observe structural changes over time.

PULMONARY FUNCTION TESTS

Test Results Interpretation:
  • PEAK EXPIRATORY FLOW METER:
      - Green Zone: Well-Controlled
      - Yellow Zone: Poorly-Controlled
      - Red Zone: Severe

ASTHMA: DRUG THERAPIES

  • Drug Classifications:
      - Control Therapy Drugs: Used for long-term management.
      - Reliever Drugs (Rescue): Provide quick relief.

  • Bronchodilators:
      - Types:
        - Short-acting
        - Long-acting

  • Inhaler Types:
      - Metered Dose Inhaler (MDI)
      - Dry Powder Inhaler (DPI)
      - Soft Mist Inhaler (SMI)

STATUS ASTHMATICUS

  • Definition: Severe, life-threatening acute episode of airway obstruction.

  • Characteristics:
      - Intensifies once it begins, often unresponsive to standard therapy.
      - Symptoms include labored breathing and wheezing.

  • Risks:
      - Delayed treatment can lead to pneumothorax, cardiac or respiratory arrest.

  • Treatment Protocol:
      - IV fluids
      - Potent systemic bronchodilator
      - Steroids
      - Epinephrine
      - Oxygen therapy
      - Prepare for emergency intubation if sudden absence of wheezing and low oxygen saturation occurs.

KNOWLEDGE CHECK (1)

  • Assessment Indicators of Declining Respiratory Status: (Select all that apply)
      - A. SaO2 95%
      - B. Wheezing
      - C. Retraction of sternal muscles
      - D. Pink mucous membranes
      - E. Tachycardia

KNOWLEDGE CHECK (2)

  • Medication Class to Administer: For a client with an SaO2 of 91% and abnormal respiratory effort, the expected medication is:
      - A. Antibiotic
      - B. Beta‑blocker
      - C. Antiviral
      - D. Beta2 agonist

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

  • Definition: Collection of lower airway disorders including emphysema and chronic bronchitis.
      - Impact on Function: Interferes with airflow and gas exchange, typically affects middle-aged to older adults.
      - Symptoms:
        - Characterized by bronchospasm and dyspnea that increase in severity over time, potentially leading to respiratory failure.
        - Smoking is a significant cause of COPD.

COPD EXPECTED FINDINGS

  • Symptoms:
      - Chronic dyspnea, particularly during acute exacerbations (respiratory rate may reach 40-50/min)
      - Dyspnea during exertion
      - Hypoxemia
      - Presence of crackles and wheezes
      - Rapid and shallow respirations
      - Hypercarbia
      - Right-sided heart failure signs
        - Dependent edema
        - Clubbing of fingers and toes
        - Pallor and cyanosis of nail beds and mucous membranes

EMPHYSEMA VS CHRONIC BRONCHITIS

Emphysema:
  • Identification: "Pink Puffer"

  • Characteristics:
      - Loss of lung elasticity leading to hyperinflation.
      - Symptoms include dyspnea and need for increased respiratory rate.
      - Air trapping results in enlarged alveoli and collapse of small airways.

Chronic Bronchitis:
  • Identification: "Blue Bloater"

  • Characteristics:
      - Defined by inflammation of bronchi and bronchioles due to chronic irritant exposure.
      - Characterized by excessive mucus production affecting only airways.

COPD ASSESSMENT

  • Areas to Assess:
      - History: Focus on risk factors like smoking, breathing problems, activity limitations, and weight.
      - Physical examination: General appearance and respiratory changes, including lung auscultation.
      - Psychosocial: Impact on daily life.

COPD: LABS/DIAGNOSTICS

  • Diagnostic Tools:
      - Hematocrit Levels: Increased due to low oxygenation.
      - Sputum Cultures and WBC Counts: Help diagnose acute respiratory infections.
      - Arterial Blood Gases (ABGs):
        - Hypoxemia indicates decreased PaO2PaO_2 (less than 80 mm Hg).
        - Hypercarbia indicates increased PaCO2PaCO_2 (greater than 45 mm Hg).
      - Bloodwork: CBC, CMP, and Pulmonary Function Tests

COPD: NURSING INTERVENTIONS

  • Priority: Airway management

  • Goals:
      - Promote gas exchange
      - Prevent weight loss
      - Minimize anxiety

  • Therapeutic Methods:
      - Oxygen therapy
      - Breathing techniques:
        - Diaphragmatic (abdominal) breathing
        - Purse-lipped breathing
      - Positive Expiratory Pressure (PEP) Device

COPD: SURGICAL MANAGEMENT

  • Lung Volume Reduction Surgery (LVRS):
      - Focus on removing hyperinflated lung tissue.
      - Goals:
        - Increase expiratory volume
        - Decrease lung capacity and residual volume

COPD: CLIENT EDUCATION

  • Recommendations:
      - Consume high-calorie foods to support energy needs.
      - Rest as required.
      - Maintain hand hygiene to prevent infections.
      - Adhere strictly to prescribed medication regimens (inhalers, oral meds).
      - Smoking cessation if needed.
      - Obtain vaccinations (influenza, pneumonia).
      - Use oxygen as prescribed; inform caregivers about the risks of smoking near oxygen.
      - Report unusual findings to healthcare provider.
      - Ensure adequate fluid intake (approximately 2 L or 68 oz daily) unless otherwise advised.

LUNG CANCER

  • Overview: Leading cause of cancer-related deaths with poor long-term prognosis due to late diagnosis.

  • Types:
      - Bronchogenic carcinomas:
        - Small cell lung cancer
        - Non-small cell lung cancer

  • Risk Factors:
      - Repeated exposure to inhaled carcinogens
      - Air pollution
      - Radiation exposure

LUNG CANCER: ASSESSMENT

  • Patient History:
      - Consider smoking and other risk factors (workplace, residence).

  • Physical Examination: Look for symptoms such as:
      - Hoarseness
      - Coughing
      - Sputum production
      - Hemoptysis
      - Shortness of breath
      - Changes in endurance
      - Chest pain

  • Labs/Diagnostics:
      - Biopsy
      - Examination of pleural effusion fluid

LUNG CANCER: NONSURGICAL TREATMENT

  • Treatment Modalities:
      - Chemotherapy (including targeted therapy)
      - Radiation therapy
      - Photodynamic therapy

LUNG CANCER: SURGICAL MANAGEMENT

  • Options:
      - Lobectomy
      - Pneumonectomy
      - Segmentectomy
      - Wedge resection
      - Median sternotomy
      - Surgical approaches:
        - Posterolateral incision
        - Anterolateral incision

LUNG CANCER: POSTOPERATIVE CARE

  • Post-operative management includes:
      - Monitoring: Patient will have a chest tube to drain accumulated air and blood in pleural space, facilitating lung re-expansion.
      - Ensure dressing around the site is dry and intact.
      - Listen for breath sounds.
      - Promote coughing and deep breathing exercises.
      - Manage pain effectively.

LUNG CANCER: PALLIATIVE CARE

  • Focus: Managing symptoms and improving quality of life through:
      - Oxygen therapy
      - Radiation therapy
      - Thoracentesis
      - Strategies for dyspnea management
      - Pain management